PACE-CME

Treatment goals for LDL-c-lowering and emerging evidence for the importance of Lp(a)

Treatment goals for LDLclowering and emerging evidence for the importance of Lpa
RestartResume
10' education - May 26, 2020 - Prof. J. Wouter Jukema, MD - Leiden, The Netherlands
  • Overview

    Prof. Jukema explains the main principles for LDL-c-lowering therapy as described in the 2019 ESC/EAS guidelines and discusses results from several trials that investigated the effect of Lp(a) on CV outcomes.

  • Faculty

    Prof. J. Wouter Jukema, MD is Professor of Cardiology at the Leiden University Medical Center in Leiden, The Netherlands.

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free